This is exactly the spike in my mind
Release time:
2020-12-01
This is exactly the spike in my mind
March was supposed to be the spring season, but this year's March is more special, the haze of the epidemic is still hanging over everyone's heart, people are still a little panic, in such an environment, I have the first contact with the spike.
accompanied by friends, through the interview, waiting for the notice of work, the heart is looking forward to but restless. More and more people go out in the village, the village is more and more empty, and the air is suffocating. After receiving the notice, I thought I could soothe this uneasy heart, but another question appeared...
The people and things in April were quiet, soft, warm and peaceful. On the first day of April, my heart blossomed as I got closer to the spikes. In more than ten days, I learned that Jianfeng has become the first listed company in the national cement industry step by step from Zhejiang Jinhua cement Plant, with a history of more than 60 years. Jianfeng Pharmaceutical has also been rated as one of the top 100 pharmaceutical enterprises in the country, the top ten pharmaceutical industry enterprises in Zhejiang Province, and the key high-tech enterprises of the National Torch Program. These are enough to make my little heart proud.
But my major has nothing to do with my position. In this new job, many factors will make me afraid, nervous and worried that I will not do well. We all know the truth that everything is difficult before it is easy, so we will fight for it when we come. At the same time, I am lucky. In the face of an inexperienced little white like me, the boss not only teaches us carefully in his work, but also teaches us how to deal with people. When I do something wrong, I will criticize but also do not forget to encourage, just like the teachers on campus, waiting patiently for us to grow up. I really answered that sentence: enterprises are universities without walls.
The first colleagues we met were three girls we had never met before, but we were very speculative. We talked endlessly together, learned about peak history together, became familiar with corporate culture together, and then set foot on the road from Guizhou to Daye and from Daye to Guizhou together. We faced difficulties together, studied together and worked hard together. This kind of sincere feeling is really good. Thank you for accompanying me from unfamiliar to familiar, from familiar to clear. I am no longer afraid of the doubts in my heart.
Now I recall that over the past seven months or so, whether in Daye Peak or Huang Ping Peak, I can feel the warmth of home. This feeling has poured into my heart more than once. This is exactly the environment I want, the peak in my mind, and the answer in my heart! (Long Liwei)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page